These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6666224)

  • 1. Anti-ischemic effects of an 80-mg tablet of isosorbide dinitrate in sustained-release form before and after 2 weeks treatment with 80 mg once daily or twice daily.
    Silber S; Krause KH; Garner C; Theisen K; Jahrmärker H
    Z Kardiol; 1983; 72 Suppl 3():211-7. PubMed ID: 6666224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equal anti-ischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, double-blind and crossover study.
    Silber S; Vogler A; Theisen K
    Z Kardiol; 1986; 75 Suppl 3():100-5. PubMed ID: 3541414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
    Blasini R; Brügmann U; Reiniger G; Rudolph W
    Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
    Reiniger G; Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tolerance to a sustained release form of isosorbide dinitrate: comparison between 20 mg four times and 40 mg twice-daily administrations].
    Hiasa Y; Hamai K; Wada T; Ootani R; Shinohara H; Aihara T; Bando M; Nakai Y; Kataoka Y
    Kokyu To Junkan; 1991 Sep; 39(9):925-30. PubMed ID: 1749871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction and circumvention of nitrate tolerance applying different dosage intervals.
    Silber S; Vogler AC; Krause KH; Vogel M; Theisen K
    Am J Med; 1987 Nov; 83(5):860-70. PubMed ID: 3674093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
    Kośmicki M; Sadowski Z; Szwed H; Kowalik I
    Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance development during isosorbide dinitrate treatment: can it be circumvented?
    Rudolph W; Blasini R; Reiniger G; Brügmann U
    Z Kardiol; 1983; 72 Suppl 3():195-8. PubMed ID: 6421009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment and tolerance with high doses of isosorbide dinitrate in a slow release form in patients with angina pectoris.
    Becker HJ; Fach WA; Weil J; Hüwer HD
    Z Kardiol; 1983; 72 Suppl 3():199-202. PubMed ID: 6666222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of eccentric dosing with sustained-release isosorbide dinitrate in patients with angina pectoris.
    Parker JO; Baird MG
    Can J Cardiol; 1994 Nov; 10(9):909-12. PubMed ID: 7954026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M; Sadowski Z
    Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nycthemeral changes in plasma concentrations of active nitrate derivatives. Comparison of a single dose of LP 60mg isosobide dinitrate and LP 20mg isosobide dinitrate administered 3 times daily].
    Ollivier JP; Pello JY; Auclert L; Dorléac D; Guillou J; Olive G
    Arch Mal Coeur Vaiss; 1992 Apr; 85 Spec No 1():17-20. PubMed ID: 1530423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of symptomatic and asymptomatic myocardial ischemia using 120 mg delayed-action ISDN].
    Reiniger G; Lehmann G; Beyerle A; Wolf H; Rudolph W
    Herz; 1990 Aug; 15(4):259-65. PubMed ID: 2210597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Avoidance of tolerance development to long term therapy with nitrates through correct dosage].
    Blasini R; Reiniger G; Rudolph W
    Z Kardiol; 1986; 75 Suppl 3():42-9. PubMed ID: 3541418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long term therapy of coronary heart disease with 120 mg slow release isosorbide dinitrate once a day. Study of duration of action and development of tolerance].
    Ohlmeier H; Mertens HM; Möller M; Mannebach H; Gleichmann U
    Z Kardiol; 1986; 75 Suppl 3():50-6. PubMed ID: 3541419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrate therapy without loss of action by correct dosage.
    Boertz A; Bonn R
    Z Kardiol; 1986; 75 Suppl 3():57-60. PubMed ID: 3798996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic measurements and exercise testing to assess the development of tolerance against slow-release isosorbide dinitrate.
    Weidemann H; Schuon J; Schober B
    Z Kardiol; 1983; 72 Suppl 3():229-32. PubMed ID: 6666226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamics and coronary dynamics under ISDN long-term therapy].
    Wortmann A; Bachmann K; Deuber HJ; Roth E
    Z Kardiol; 1986; 75 Suppl 3():68-76. PubMed ID: 3798997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.